查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964122

全球妊娠检测设备市场－产业规模、份额、趋势、机会和预测：按产品类型、技术、分销管道、地区和竞争格局划分，2021-2031年

Pregnancy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Technology, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球妊娠检测设备市场预计将从 2025 年的 16.9 亿美元成长到 2031 年的 23.2 亿美元，复合年增长率为 5.42%。

这些诊断设备旨在检测尿液或血清中的人类绒毛膜促性腺激素分泌(hCG)，被定位为确认怀孕的主要方法。市场成长主要受全球意外妊娠高发生率的驱动。随着女性延后生育，积极进行生育管理的意愿日益增强，对便利、即时的妊娠确认方法的需求也变得特别迫切。根据联合国人口基金会的数据，该基金的生殖健康计画在2024年预防了约1,800万例意外怀孕。这项数据凸显了庞大的生殖活动规模，也凸显了可靠诊断解决方案的重要性。

市场概览
预测期 2027-2031
市场规模：2025年 16.9亿美元
市场规模：2031年 23.2亿美元
复合年增长率：2026-2031年 5.42%
成长最快的细分市场 尿液
最大的市场 北美洲

儘管市场需求强劲，但家用检测的准确性和结果解读方面仍面临许多挑战。操作失误和使用者生理限制常常导致测量结果不准确，加剧消费者的不信任感，并造成不必要的就医。新兴经济体严格的法规环境更使这一可靠性问题雪上加霜，延缓了改进型检测方法的核准，限制了民众获得可靠诊断设备的途径。

市场驱动因素

数位和互联诊断技术的创新正在改变全球妊娠检测市场，满足消费者对卫生和便利的偏好。唾液检测等新型方法因其非侵入性而迅速普及，避免了传统尿液检查试纸带来的不适感。例如，根据《富比士》2024年12月的一篇报导报道，Salignostics公司在推出后不久便售出了超过50万套唾液检测套组，这表明产品设计正朝着以用户为中心的方向发生决定性转变。此外，该产业的经济规模也持续扩大。根据Femtech Insider 2025年11月的报告，光是德国的自我检测市场在2024年就创造了约5.08亿美元的收入，这充分展现了个人健康监测工具的巨大经济潜力。

同时，不孕症上升和生育年龄延迟的趋势正在改变市场动态，使其从被动确认转向主动生育管理。随着女性生育年龄的推迟，生育期缩短，因此需要更频繁、更精确的检测来监测生殖週期。根据美国疾病管制与预防中心（CDC）2025年7月发布的初步数据，美国总和生育率在2024年将降至每千名女性53.8个。然而，矛盾的是，生育率的下降反而推动了市场成长，因为受孕困难导致夫妻更加依赖辅助生殖技术通讯协定和诊断设备来制定严格的计划生育策略。

市场挑战

全球验孕市场面临的主要挑战在于难以确保家用验孕棒的准确性和结果的正确解读。使用不当（例如检测时间不当或检体采集不足）常常导致假阳性结果，从而削弱消费者的信心。当家用验孕棒的可靠性无法得到保证时，消费者不太可能依赖这些设备进行即时确认，而更倾向于寻求专业医疗干预。这种消费者的不信任是市场渗透的一大障碍，尤其对于新产品而言，因为对误诊的担忧往往超过了家用验孕棒带来的便利。

严格的法规结构旨在保障安全，但这进一步加剧了这项挑战。新兴市场和已开发国家的监管机构都在实施日益严格的临床证据要求，从而延缓了改进型、更便捷的检测方法的核准流程。根据欧洲医疗技术协会（MedTech Europe）预测，到2024年，30%的体外诊断设备製造商将因严格的性能评估而在设备认证方面遭遇重大延误或失败。这些延误阻碍了能够减少使用者操作失误的先进解决方案的快速普及，也削弱了企业应对市场变化和满足消费者对可靠性需求的能力。

市场趋势

在消费者对环保诊断解决方案日益增长的需求推动下，整个产业正经历着向可生物降解和水溶性材料转型的重要转变。製造商们越来越重视塑胶中和设计，摒弃传统的不可可再生外壳，以减少一次性诊断试剂盒产生的大量废弃物。随着企业力求在不影响诊断准确性的前提下实现全球永续性目标，这项转变正在推动产品开发平臺的重组。作为这项商业性策略的佐证，Abingdon Health 公布了截至 2025 年 3 月的财年中期业绩，显示其 2025 财年上半年营收达 310 万英镑，证实了其永续妊娠检测套组即将在美国上市，并凸显了环保创新对企业的高度重视。

同时，直接面向消费者 (DTC) 和线上订阅模式的扩张正在革新市场进入，满足了消费者对隐私和物流便利的需求。与传统零售不同，这些以数位优先的管道提供私密的订阅服务，使用户能够在家中进行生殖健康监测，并避免前往药房可能带来的不便。这种分销模式的转变得益于强大的数位化互动。根据 Church & Dwight 公司 2025 年 1 月的公布财报，2024 年线上销售额占全球总销售额的 21.4%，反映出消费者在个人保健产品方面的购买行为正显着转向数位化平台。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球妊娠检测设备市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类型（尿液检查、血液检查）
    • 按技术（线指示器、数位检测）
    • 分销通路（零售药局、网路药局、医院药局）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美妊娠检测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲妊娠检测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区妊娠检测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲妊娠检测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲妊娠检测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球妊娠侦测设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Abbott
  • Roche
  • BD
  • Siemens Healthineers
  • Beckman Coulter
  • Acon Laboratories
  • SD Biosensor
  • Hologic
  • AmniSure
  • Quest Diagnostics

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25294

The Global Pregnancy Testing Devices Market is projected to expand from USD 1.69 billion in 2025 to USD 2.32 billion by 2031, registering a CAGR of 5.42%. These diagnostic instruments, designed to detect human chorionic gonadotropin in urine or serum, remain the primary method for confirming conception. The market's growth is fundamentally propelled by the high global prevalence of unintended pregnancies, which creates a critical need for accessible and immediate confirmation methods, alongside a rising focus on proactive fertility management among women delaying childbirth. Data from the United Nations Population Fund indicates that in 2024, their reproductive health programs averted approximately 18 million unintended pregnancies, a statistic that underscores the vast scale of reproductive activity necessitating reliable diagnostic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.69 Billion
Market Size 2031USD 2.32 Billion
CAGR 2026-20315.42%
Fastest Growing SegmentUrine based
Largest MarketNorth America

Despite this strong demand, the market encounters significant hurdles related to the accuracy and interpretation of home-based test results. Procedural errors by users or physiological limitations often result in false readings, fostering consumer skepticism and leading to unnecessary medical consultations. This issue of reliability is frequently compounded by rigorous regulatory environments in emerging economies, which often delay the approval of enhanced testing formats and limit the general population's access to dependable diagnostic devices.

Market Driver

Technological innovations in digital and connected diagnostics are transforming the Global Pregnancy Testing Devices Market by satisfying consumer preferences for hygiene and simplicity. Novel methods, such as saliva-based testing, are rapidly gaining traction as non-invasive alternatives that eliminate the discomfort associated with traditional urine strips. For instance, a Forbes article from December 2024 noted that Salignostics sold over 500,000 units of its saliva-based test shortly after launch, signaling a decisive shift toward user-centric product designs. Furthermore, the economic scale of this segment is widening; a November 2025 report from Femtech Insider highlighted that Germany's self-testing market alone generated approximately $508 million in 2024, demonstrating the robust financial potential of private health monitoring tools.

Concurrently, the rising prevalence of infertility and the trend of delayed parenthood are shifting market dynamics from reactive confirmation to proactive fertility management. As women increasingly postpone childbirth, the biological window for conception narrows, requiring frequent and precise testing to monitor reproductive cycles. According to provisional data released by the Centers for Disease Control and Prevention in July 2025, the U.S. general fertility rate fell to 53.8 births per 1,000 females in 2024. Paradoxically, this decline stimulates market growth, as the difficulty in conceiving compels couples to rely more heavily on diagnostic devices for assisted reproduction protocols and rigorous family planning strategies.

Market Challenge

A major obstacle impeding the Global Pregnancy Testing Devices Market is the challenge of ensuring accuracy and correct interpretation of home-based results. User procedural errors, such as improper timing or sample collection, frequently yield false readings that erode consumer confidence. When individuals cannot trust the reliability of a home test, they are less likely to rely on these devices for immediate confirmation, often turning to professional medical intervention instead. This consumer distrust creates a significant barrier to market penetration, particularly for new product adoption, as the fear of misdiagnosis often outweighs the convenience offered by at-home testing.

This challenge is further intensified by stringent regulatory frameworks which, while designed to guarantee safety, create substantial bottlenecks for market growth. Regulatory bodies in both emerging and developed economies are enforcing stricter clinical evidence requirements, slowing the approval process for improved, more user-friendly testing formats. According to MedTech Europe, in 2024, 30% of In Vitro Diagnostic manufacturers reported significant delays or negative outcomes regarding device certification due to rigorous performance evaluations. These delays prevent manufacturers from swiftly introducing advanced solutions that could mitigate user errors, thereby stalling the market's ability to evolve and meet consumer demand for reliability.

Market Trends

The industry is witnessing a significant shift toward the adoption of biodegradable and flushable materials, driven by escalating consumer demand for environmentally responsible diagnostic solutions. Manufacturers are increasingly prioritizing plastic-neutral designs to mitigate the substantial waste generated by single-use diagnostic kits, moving away from traditional non-recyclable casings. This transition is reshaping product development pipelines as companies seek to align with global sustainability goals without compromising diagnostic accuracy. As evidence of this commercial focus, Abingdon Health's March 2025 interim results reported H1 2025 revenues of £3.1 million and confirmed the upcoming U.S. launch of its sustainable pregnancy tests, underscoring the prioritization of eco-friendly innovations.

Simultaneously, the expansion of direct-to-consumer (DTC) and online subscription models is revolutionizing market access by addressing the consumer need for privacy and logistical convenience. Unlike traditional retail purchasing, these digital-first channels offer discreet, recurring deliveries that allow individuals to manage reproductive health monitoring from home, bypassing the potential discomfort of pharmacy visits. This distribution shift is supported by robust digital engagement; according to Church & Dwight Co., Inc.'s January 2025 earnings call, online sales accounted for 21.4% of their total global sales in 2024, reflecting a significant migration of consumer purchasing behavior toward digital platforms for personal care products.

Key Market Players

  • Abbott
  • Roche
  • BD
  • Siemens Healthineers
  • Beckman Coulter
  • Acon Laboratories
  • SD Biosensor
  • Hologic
  • AmniSure
  • Quest Diagnostics

Report Scope

In this report, the Global Pregnancy Testing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pregnancy Testing Devices Market, By Product Type

  • Urine based
  • Blood based

Pregnancy Testing Devices Market, By Technology

  • Line Indicator
  • Digital Test

Pregnancy Testing Devices Market, By Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

Pregnancy Testing Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pregnancy Testing Devices Market.

Available Customizations:

Global Pregnancy Testing Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pregnancy Testing Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Urine based, Blood based)
    • 5.2.2. By Technology (Line Indicator, Digital Test)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pregnancy Testing Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Technology
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pregnancy Testing Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Pregnancy Testing Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Pregnancy Testing Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Distribution Channel

7. Europe Pregnancy Testing Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technology
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pregnancy Testing Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Pregnancy Testing Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Pregnancy Testing Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Pregnancy Testing Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Pregnancy Testing Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Pregnancy Testing Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pregnancy Testing Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Pregnancy Testing Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Pregnancy Testing Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Pregnancy Testing Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Pregnancy Testing Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Pregnancy Testing Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technology
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pregnancy Testing Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Pregnancy Testing Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Pregnancy Testing Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Distribution Channel

10. South America Pregnancy Testing Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technology
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pregnancy Testing Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Pregnancy Testing Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Pregnancy Testing Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pregnancy Testing Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Roche
  • 15.3. BD
  • 15.4. Siemens Healthineers
  • 15.5. Beckman Coulter
  • 15.6. Acon Laboratories
  • 15.7. SD Biosensor
  • 15.8. Hologic
  • 15.9. AmniSure
  • 15.10. Quest Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer